• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD 0.00% 2.4¢

ADALTA LIMITED

AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company... AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II clinical trials with applications in the fields of inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic for the treatment of fibrotic diseases, including lung fibrosis (specifically Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD)), kidney fibrosis, eye fibrosis and some cancers. Chimeric Antigen Receptor (CAR) cell therapies involve modification of a patient’s immune cells (T cells, NK cells, macrophages and other) so that they produce a CAR on the cell surface that enables the patient’s immune system to recognize and kill diseased cells such as cancer. It develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology. It evaluates several CXCR4 i-bodies.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AD 10:58 118 19K
10:58 Last post  JabraD Comments Created with Sketch.  118  Views Created with Sketch.  19K 
1AD 15/03/24 1 276
15/03/24 Last post  debono Comments Created with Sketch.  1  Views Created with Sketch.  276 
1AD 13/03/24 148 25K
13/03/24 Last post  JabraD Comments Created with Sketch.  148  Views Created with Sketch.  25K 
1AD 12/03/24 12 2.6K
12/03/24 Last post  asx11 Comments Created with Sketch.  12  Views Created with Sketch.  2.6K 
1AD
Countdown on to Adalta Trial Results
2
06/03/24 85 13K
06/03/24 Last post  JelloB Comments Created with Sketch.  85  Views Created with Sketch.  13K 
1AD 01/03/24 62 15K
01/03/24 Last post  asx11 Comments Created with Sketch.  62  Views Created with Sketch.  15K 
1AD 01/03/24 2 569
01/03/24 Last post  asx11 Comments Created with Sketch.  2  Views Created with Sketch.  569 
1AD 27/02/24 0 240
27/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  240 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - 1AD
15 Mar 11:14
 
Corporate Presentation
08 Mar 08:18
 
Share Cafe webinar on Phase I results
07 Mar 08:19
 
Positive AD-214 Phase I extension study results
06 Mar 08:35
 
Half Yearly Report and Accounts
27 Feb 08:09
 
Australia Biologics Festival Presentation
20 Feb 08:29
 
View More arrow Created with Sketch.
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $12.62M
Open High Low Value Volume
2.4¢ 2.5¢ 2.4¢ $34.32K 1.422M

Buyers (Bids)

No. Vol. Price($)
2 231891 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 10126 1
View Market Depth
Last trade - 12.18pm 19/03/2024 (20 minute delay) ?
Last
2.4¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
2.4¢ 2.4¢ 2.4¢ 513432
Last updated 12.18pm 19/03/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.